The prevalence of iron deficiency and anemia and their impact on survival in patients at a cardio-oncology clinic

Cardio-Oncology

Table 4 Factors affecting survival

Factor	Category	HR (95% CI)	*P-value*
Gender	Male	1.704 (1.207–2.404)	*p = 0.002*
Age		1.016 (1.004–1.028)	*p = 0.011*
Previous cancer history	Yes	1.879 (1.079–3.272)	*p = 0.026*
BNP	Elevated	2.126 (1.258–3.590)	*p = 0.005*
LVEF	< 50%	1.101 (0.721–1.683)	p = 0.655
GFR	< 60 ml/min/1.73 m²	1.255 (0.838–1.879)	p = 0.270
TSAT	< 20%	1.721 (1.214–2.439)	*p = 0.002*
Ferritin	20–100 μg/L	1.004 (0.532–1.892)	p = 0.991
Ferritin	≥100 μg/L	2.008 (1.088–3.706)	*p = 0.026*
ID	FID	2.538 (1.162–3.981)	*p < 0.001*
Serum iron	< 12 umol/L	2.292 (1.614–3.255)	*p < 0.001*
Anemia	Yes	2.462 (1.734–3.495)	*p < 0.001*

HR Hazard ratio, BNP Brain natriuretic peptide, LVEF Left ventricular ejection fraction, GFR Glomerular filtration rate, TSAT Transferrin saturation, ID Iron deficiency, FID Functional iron deficiency

ISSN: 2057-3804